Sutro Biopharma, Inc.STRONASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P71
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 30.78% |
| Q3 2025 | 14.61% |
| Q2 2025 | 34.12% |
| Q1 2025 | 5.37% |
| Q4 2024 | -11.19% |
| Q3 2024 | -782.35% |
| Q2 2024 | 114.60% |
| Q1 2024 | -560.07% |
| Q4 2023 | 142.00% |
| Q3 2023 | -7.40% |
| Q2 2023 | 48.85% |
| Q1 2023 | -155.58% |
| Q4 2022 | -136.24% |
| Q3 2022 | 2166.98% |
| Q2 2022 | 90.96% |
| Q1 2022 | -63.37% |
| Q4 2021 | 11.58% |
| Q3 2021 | -363.73% |
| Q2 2021 | 82.70% |
| Q1 2021 | -61.18% |
| Q4 2020 | -6.73% |
| Q3 2020 | -41.51% |
| Q2 2020 | 33.28% |
| Q1 2020 | -42.40% |
| Q4 2019 | 18.39% |
| Q3 2019 | -3.33% |
| Q2 2019 | 22.56% |
| Q1 2019 | -239.43% |
| Q4 2018 | -112.48% |
| Q3 2018 | 441.15% |
| Q2 2018 | 7.10% |
| Q1 2018 | -210.12% |
| Q4 2017 | -137.49% |
| Q3 2017 | 86.50% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |